Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

56.02 -0.18 (-0.32%)
Streaming Delayed Price Updated: 11:28 AM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catalent Inc

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
Danaher Corporation (NYSE: DHR) has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc (NYSE: CTLT). 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday! 
Via InvestorPlace
Nasdaq Futures Indicate Subdued Start For Wall Street: Jerome Powell's Speech On Tuesday Key Highlight This Week
Stock futures indicate major Wall Street indices are expected to open lower this week that will see a crucial speech by Federal Reserve Chair Jerome Powell at the Economic Club of Washing 
Via Benzinga
Analyst Ratings for Catalent
Via Benzinga
Barclays Maintains Overweight Rating for Catalent: Here's What You Need To Know
Via Benzinga
Why Shares of Catalent Fell 36% This Week
Lowered guidance and earnings concerned investors. 
Via The Motley Fool
Why PayPal And Coinbase Are Trading Lower; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader
From Catalent, Inc.
Via Business Wire
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand. 
Via Benzinga
Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate
From Catalent, Inc.
Via Business Wire
Catalent, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Catalent, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Via Benzinga
Catalent Announces Changes to its Board of Directors
From Catalent, Inc.
Via Business Wire
Can Stocks Buck The Rising Odds Of A Recession?
The S&P 500 rose 1.1% and ended the week above its 200-day moving average. Fed Chair Powell spurred a strong rally in stocks on Wednesday, saying interest rates could rise less in December compared to... 
Via Talk Markets
Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13
Benzinga Sam Bankman-Fried Arrested In The Bahamas 
Via Benzinga
After US Launch Bottlenecks, Novo Nordisk Pushes European Rollout For Wegovy In 2023
Novo Nordisk A/S (NYSE: NVO) will roll out its obesity treatment, Wegovy (semaglutide), in Europe in 2023 to ensure it has enough supply. 
Via Benzinga
After a $100 Haircut, is Catalent an Oversold Pharma Play?
With the macro backdrop weakening for Catalent’s pharmaceutical and biotech customers, fundamental concerns could outweigh what the charts suggest. 
Via MarketBeat
Catalent, Inc. to Present at the Stephens Annual Investment Conference
From Catalent, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022
Upgrades 
Via Benzinga
Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline
From Exelixis, Inc.
Via Business Wire
Where Catalent Stands With Analysts
Over the past 3 months, 11 analysts have published their opinion on Catalent (NYSE:CTLT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
Upgrades 
Via Benzinga
Analyst Ratings for Catalent
Over the past 3 months, 8 analysts have published their opinion on Catalent (NYSE:CTLT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Catalent Stock Plummeted by Nearly 25% Today
Flat revenue growth, a sharp decline in profitability, and reduced guidance combined to make an awful day for the company. 
Via The Motley Fool
Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 70 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Unity Biotechnology (UBX) Stock Pops on Positive Study Data
Unity Biotechnology (UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical trial of UBX1325. 
Via InvestorPlace
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.